- Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017-06-20)
Arik Dahan, Milica Markovic, Svetlana Epstein, Noa Cohen, Ellen M Zimmermann, Aaron Aponick, Shimon Ben-Shabat
PMID28627471
摘要
The enzyme phospholipase A
材料